Pulse Biosciences Past Earnings Performance
Past criteria checks 0/6
Pulse Biosciences's earnings have been declining at an average annual rate of -2%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 29% per year.
Key information
-2.0%
Earnings growth rate
14.2%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 29.0% |
Return on equity | -117.2% |
Net Margin | n/a |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pulse Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 0 | -43 | 16 | 29 |
31 Dec 23 | 0 | -42 | 16 | 28 |
30 Sep 23 | 0 | -39 | 14 | 24 |
30 Jun 23 | 0 | -47 | 16 | 21 |
31 Mar 23 | 0 | -51 | 20 | 20 |
31 Dec 22 | 1 | -59 | 26 | 21 |
30 Sep 22 | 2 | -65 | 32 | 22 |
30 Jun 22 | 2 | -61 | 35 | 24 |
31 Mar 22 | 2 | -62 | 34 | 26 |
31 Dec 21 | 1 | -64 | 34 | 29 |
30 Sep 21 | 1 | -62 | 31 | 30 |
30 Jun 21 | 0 | -61 | 29 | 31 |
31 Mar 21 | 0 | -57 | 27 | 29 |
31 Dec 20 | 0 | -50 | 24 | 26 |
30 Sep 20 | 0 | -50 | 24 | 26 |
30 Jun 20 | 0 | -49 | 24 | 25 |
31 Mar 20 | 0 | -49 | 24 | 25 |
31 Dec 19 | 0 | -47 | 23 | 25 |
30 Sep 19 | 0 | -42 | 19 | 23 |
30 Jun 19 | 0 | -41 | 19 | 22 |
31 Mar 19 | 0 | -39 | 19 | 20 |
31 Dec 18 | 0 | -38 | 20 | 17 |
30 Sep 18 | 0 | -37 | 22 | 15 |
30 Jun 18 | 0 | -34 | 21 | 13 |
31 Mar 18 | 0 | -31 | 20 | 11 |
31 Dec 17 | 0 | -26 | 16 | 10 |
30 Sep 17 | 0 | -20 | 11 | 8 |
30 Jun 17 | 0 | -15 | 8 | 7 |
31 Mar 17 | 0 | -11 | 4 | 6 |
31 Dec 16 | 0 | -10 | 3 | 6 |
30 Sep 16 | 0 | -8 | 2 | 5 |
30 Jun 16 | 0 | -6 | 2 | 4 |
31 Mar 16 | 0 | -4 | 2 | 3 |
31 Dec 15 | 0 | -3 | 2 | 2 |
30 Sep 15 | 0 | -2 | 1 | 2 |
Quality Earnings: 6L8 is currently unprofitable.
Growing Profit Margin: 6L8 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6L8 is unprofitable, and losses have increased over the past 5 years at a rate of 2% per year.
Accelerating Growth: Unable to compare 6L8's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6L8 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).
Return on Equity
High ROE: 6L8 has a negative Return on Equity (-117.25%), as it is currently unprofitable.